Dysport® Treatment of Urinary Incontinence in Adults Subjects With Neurogenic Detrusor Overactivity (NDO) Due to Spinal Cord Injury or Multiple Sclerosis - Study 1 (CONTENT1)
A Phase III, Multicentre, Randomised, Double Blind, Parallel Group, Placebo Controlled Study To Assess The Efficacy And Safety Of One Or More Intradetrusor Treatments Of 600 Or 800 Units of Dysport® For The Treatment Of Urinary Incontinence In Subjects With Neurogenic Detrusor Overactivity Due To Spinal Cord Injury Or Multiple Sclerosis
Sponsor: Ipsen
Terminated
Low recruitment of patients
Listed as NCT02660138, this PHASE3 trial focuses on Overactive Bladder and Urinary Incontinence and remains terminated or withdrawn. Sponsored by Ipsen, it has been updated 21 times since 2016, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
21 versions recorded-
Sep 2025 — Present [monthly]
Terminated PHASE3
-
Sep 2024 — Sep 2025 [monthly]
Terminated PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE3
-
Sep 2022 — Jul 2024 [monthly]
Terminated PHASE3
-
Dec 2021 — Sep 2022 [monthly]
Terminated PHASE3
▶ Show 16 earlier versions
-
Sep 2021 — Dec 2021 [monthly]
Terminated PHASE3
-
Jan 2021 — Sep 2021 [monthly]
Terminated PHASE3
-
Dec 2019 — Jan 2021 [monthly]
Terminated PHASE3
-
Oct 2019 — Dec 2019 [monthly]
Terminated PHASE3
Status: Completed → Terminated
-
Aug 2019 — Oct 2019 [monthly]
Completed PHASE3
-
May 2019 — Aug 2019 [monthly]
Completed PHASE3
Status: Active Not Recruiting → Completed
-
Feb 2019 — May 2019 [monthly]
Active Not Recruiting PHASE3
-
Dec 2018 — Feb 2019 [monthly]
Active Not Recruiting PHASE3
Status: Recruiting → Active Not Recruiting
-
Oct 2018 — Dec 2018 [monthly]
Recruiting PHASE3
-
Aug 2018 — Oct 2018 [monthly]
Recruiting PHASE3
-
Jun 2018 — Aug 2018 [monthly]
Recruiting PHASE3
-
Jan 2018 — Jun 2018 [monthly]
Recruiting PHASE3
-
Nov 2017 — Jan 2018 [monthly]
Recruiting PHASE3
-
Aug 2017 — Nov 2017 [monthly]
Recruiting PHASE3
-
Feb 2017 — Aug 2017 [monthly]
Recruiting PHASE3
-
Jan 2017 — Feb 2017 [monthly]
Recruiting PHASE3
First recorded
Mar 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Ipsen
For direct contact, visit the study record on ClinicalTrials.gov .